GL261 In Vitro Mitotic Index Assay (Cell Proliferation)
CAT#: ITS-1022-YF223
Target Cell Organism: Mouse
Target Cell Alternative Name: Glioma 261
Target Cell Name: GL261
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Overview
This assay is to provide GL261-based In Vitro Mitotic Index Assay (Cell Proliferation) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
GL261
Target Cell Organism
Mouse
Target Cell Background
Glioma 261 (GL261) is a frequently used murine glioma model. It was induced via intracranial injection of methylcholanthrene followed by serial intracranial and subcutaneous transplantations of tumor fragments into syngeneic C57BL/6 mice. By the mid-1990s, multiple groups had established a permanent cell line from the tumor.
Target Cell Alternative Name
Glioma 261
Related Diseases
Glioma
Research Area
Oncology
Assay Name
In Vitro Mitotic Index Assay (Cell Proliferation)
Short Description
GL261-cell based In Vitro Mitotic Index Assay (Cell Proliferation)
Assay Description
Mitotic index assay is one of the old assays used to determine the number of cells that are undergoing mitosis in a specified cell population using monoclonal antibodies specific for phosphorylated histone H3 (ser28). Phosphorylated histone H3 (ser28) is considered as a main marker for mitosis and this specific phosphorylation can be utilized to calculate the mitotic index in a specified cell population.
Assay Type
Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Type Details
Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.